France -
Cancer : l'institut Curie redoute des inégalités entre patients

Les nouveaux traitements contre le cancer sont de plus en plus chers. Les médecins craignent des inégalités dans l'accès aux soins innovants.

L'Institut Curie via la 5e édition de son Observatoire Cancer Institut Curie – Viavoice a mesuré les coûts des traitements mais aussi le niveau d'information des Français à ce sujet. Selon cette étude, les anticancéreux ont déjà vu leur prix doubler en 10 ans et les projections prévoient entre 6 % et 8 % de croissance par an.

"Le risque de voir s’installer des inégalités entre les patients touchés par le cancer n’a pas disparu, au contraire. Le prix des nouveaux médicaments continue d’augmenter, de sorte qu’arrivera forcément le moment où l’accès de tous les patients aux anticancéreux innovants ne sera plus possible" explique Pr Thierry Philip, président de l’Institut Curie...

Latest news

Europe -
New standards for haemophilia patients care in Council of Europe Resolution

The Council of Europe’s decision-making body, the Committee of Ministers, adopted Resolution CM/Res(2017)43 on principles concerning haemophilia therapies at the end of 2017. Elaborated by the European Committee on Blood Transfusion (CD-P-TS) on the basis of the recommendations from the Wildbad Kreuth Initiative IV meeting « Optimal use of clotting factors and platelets » of 2016*, the new Resolution replaces Resolution CM/Res (2015)3 on the same subject and calls on governments to take into account specific principles for the treatment of haemophilia and care for haemophilia patients...

Study -
Acne Can Be More Distressing Than Melanoma

Acne can have wider-ranging and longer-term effects than skin cancer, according to the Global Burden of Disease Study, an initiative for quantifying health costs funded by the Bill and Melinda Gates Foundation. The new system for ranking skin diseases by injury they cause could shift research priorities and change the way dermatologists see their patients, senior author Robert Dellavalle, MD, PhD, from the University of Colorado in Denver, told Medscape Medical News . "It affects my clinical practice in giving more priority and thought to inflammatory skin disease," said Dellavalle. His...

Guidelines -
New C difficile Guidelines Refine Diagnosis, Add FMT

The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America have updated the 2010 clinical practice guidelines on Clostridium difficile infection (CDI) in adults. The update adds recommendations for children, refines combinations and sequences of diagnostic tests, and changes antibiotic choices. It also, for the first time, includes guidance for implementing fecal microbiota transplantation (FMT). The guidelines are published in Clinical Infectious Diseases . In the United States, CDI kills 15,000 to 30,000 people annually and costs more than $4.8 billion...



Make sure you don't miss latest news, stay tuned!